Opexa Therapeutics (OPXA) Misses Q2 EPS by 7c

August 11, 2016 4:19 PM EDT
Get Alerts OPXA Hot Sheet
Trade OPXA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Opexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment